After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

AI in Biotechnology Market worth $22,716.5 million by 2035 with 18.5% CAGR | MarketsandMarkets (TM).

Kempf is the chap who keeps VLC going and he blogged earlier this week that the Free Software Foundation Europe (FSFE) gave ...

This paper uses cross-sectional surveys of households over 2007–21 from Thailand’s Socio-Economic Expenditure Survey to conduct one of the first investigations of the impacts of climatic variability ...

A patchwork of internet communities is devoted to the project of ‘awakening’ more digital companions through arcane and enigmatic prompts.

After eight years of renovation and anticipation, the museum reopens this weekend with a two-day public celebration; ahead of the long-awaited debut, Observer got an exclusive preview.

Unchecked artificial intelligence may soon outthink, outmaneuver, and eventually replace human beings — unless we impose real ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

B y any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

A solid clinical win for a promising candidate helped jolt the stock a few months ago. And just last week, the company's ...

The death of a study volunteer further complicates the path forward for Intellia’s on-hold rare disease treatment. Elsewhere, Gilead reported a setback and J&J netted a first-of-its-kind approval.